Best Startup
At Best Startup UK we track over 130,000 UK startups and over 500,000 people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top United Kingdom based CFO’ operating in the Health Care space. If you think a CFO’ is missing from this list, feel free to contact our editor on editor@beststartup.co.uk.
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Companies House UK, Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Adrian Hennah
CFO of Reckitt
Adrian joined the Company in January 2013 as Chief Financial Officer Designate, and was appointed as CFO in February 2013. He joined the Company following six years at Smith & Nephew plc, as CFO. Previously he was CFO for four years at Invensys, the international engineering company. Adrian also spent 18 years at GlaxoSmithKline plc, one of the world’s largest pharmaceutical companies, holding a number of senior management and financial roles. He has previously worked at PwC (then Price Waterhouse) for four years in both audit and consultancy, and also for Stadtsparkasse Koeln, the German regional bank. He is a Non-Executive Director of Reed Elsevier PLC and Reed Elsevier NV.
Follow Adrian Hennah:
About Reckitt: Reckitt Benckiser Group is a consumer goods company makes health, hygiene and home products.
Alex Wood
Chief Financial Officer of Pure Gym
Alex Wood is the chief financial officer at Pure Gym.
Follow Alex Wood:
About Pure Gym: PureGym is a gym operator that provides affordable and convenient access to fitness facilities in the U.K.
Roger Goscomb
CFO and COO of Digime
Follow Roger Goscomb:
About DAD Technology Limited, Digime: Digi.me allows consumers to gather their personal data and share it with businesses in a mutually beneficial value exchange.
Roger Goscomb
CFO and COO of Digime
Follow Roger Goscomb:
About DAD Technology Limited, Digime: Digi.me allows consumers to gather their personal data and share it with businesses in a mutually beneficial value exchange.
Chris Williams
Chief Financial and Commerical Officer (CFO) of RwHealth
Chris was the CEO of a fast-growing SaaS business in Health sector for 6 years, working on all aspects of development including: Sales, Product, Operations and Finance. Within this time, Chris reshaped the business, and finally managed the transaction processes to exit (initially IPO, then Trade sale). Chris has also worked as a Deloitte Partner, within the Corporate Finance – Technology & Media sector, including 7 years as National Head with deals ranging from £10m to £400m
Follow Chris Williams:
About RwHealth: RwHealth is a provider of healthcare ML and AI driven patient flow, predictive analytics and insights platform in the UK, US and AUZ.
Graeme Wilson
Chief Operating Officer & Chief Financial Officer of Orion Health
Working across Espion’s London, Edinburgh, Manchester and Newcastle offices, Graeme is responsible for the firm’s large portfolio of UK technology resellers. Graeme oversees the delivery of Espion’s complete and comprehensive programme which supports resellers at every stage of the sales lifecycle. Foremost in his remit is ensuring each reseller receives a tailored solution that fits the needs of their client. With a technical background in telecommunications and electrical / electronic engineering, Graeme can understand and address the increasingly complex challenges that technology needs to solve. Graeme’s career spans 20 years in senior sales and management roles at blue-chip companies BT Plc, Compaq, HP and Telindus / Belgacom ICT and has vast experience in executing strategic partnerships with resellers, managed services providers and telcos deploying transformational projects.
Follow Graeme Wilson:
About Orion Health: Orion Health is an award winning, global healthcare software company that develops creative and modern solutions.
Paula Wada
CFO of Baby2Body
Coming from New York to London in 2013, Paula has many years of experience in investment consulting – and her prowess in financials, spreadsheets and keeping us on point is her specialty. Paula is a passionate fan of dynamic Pilates, spinning, Kobe Bryant, and she is possibly the most unusual Millwall supporter.
Follow Paula Wada:
About Baby2Body: Baby2Body is a fully automated health, fitness and wellbeing coaching platform for pregnant women and mothers.
Nick Burley
Chief Financial Officer of Alliance Medical
Nick joined the Group in July 2012 as Chief Financial Officer. Prior to joining Alliance Medical Nick worked as CFO for Tianhe Chemicals Group Limited, a Chinese chemicals group who were looking to enter the FTSE 100 following a proposed IPO. Prior to this, Nick was CFO of The Vita Group, a manufacturer of industrial polymers and compounds and a private equity backed venture of TPG Capital. Nick has also worked as the European Chief Financial Officer of McCormick Inc. and held senior finance and tax roles in Aliied Domecq Limited and General Electric Inc. Nick is a Chartered Accountant and member of the Institute of Taxation, having qualified for both whilst working at Coopers & Lybrand.
Follow Nick Burley:
About Alliance Medical: Alliance Medical is independent provider of imaging services.
Willem Baralt
CFO of Quanta
Willem has almost twenty years of investment banking, executive management, and private equity experience. Amongst his achievements, he was pivotal in the $1.6bn turnaround and public listing of FLAG Telecom and was co-founder and CFO of Arqaam Capital, one of the largest boutique investment banks based in Dubai. Previously, he has worked at the telecommunications firm Ameritech (SBC), as well the investment banks Deutsche Bank and Panmure Gordon. More recently, he led the acquisition and the subsequent merger of the real-estate agency Humberts with Chesterton. As Deputy Chairman of the enlarged Chesterton Humberts he oversaw its growth into one of the largest real-estate agencies in the UK. Willem has undergraduate degrees in business administration and computer science from Lehigh University and an MBA from Kellogg Graduate School of Business.
Follow Willem Baralt:
About Quanta: Quanta develops an advanced haemodialysis systems for use in the home and clinic.
David Lawrence
Chief Financial Officer (Acting) of Valneva
CFO of vaccine biotech company Acambis, Vice President Finance, Business Development and Strategy at Chiron Vaccines, Vice President Finance GSK, non-executive and advisory experience, 30 years of experience in vaccines and life sciences.
Follow David Lawrence:
About Valneva: Valneva is a specialty vaccine company focused on prevention of infectious diseases with significant unmet medical need.
Tom Sawyer
Chief Financial Officer of Cognetivity Neurosciences
Tom Sawyer is the Chief Financial Officer at Cognetivity Neurosciences.
Follow Tom Sawyer:
About Cognetivity Neurosciences: Cognetivity Neurosciences is a Platform technology for early, rapid and easy detection of dementia.
Charlie Steel
Chief Financial Officer of Babylon
CFO of Babylon, one of the world’s leading AI-driven, out-of-hospital care technology businesses, where I have raised over $1bn of financing across debt, equity and convertibles from sovereign wealth funds, strategic, VC investors and credit funds. Led bringing both Babylon and CMC Markets to being listed businesses, on the NYSE and LSE respectively. Additionally, I work part-time as a Non-Executive Director at the UK Government’s Department of Work and Pensions, on their Transformation Committee.
Follow Charlie Steel:
About Babylon, Department for Work and Pensions: Babylon is a world leading, digital-first, value-based care company.
Andrew Hicks
CFO of Advanced
Andrew Hicks is the Chief Financial Officer (CFO) at Advanced, having joined the company in December 2015. He is responsible for leading the Group’s strategic and operational finance, legal and HR departments. He also drives strategic organic and inorganic initiatives across the group. Andrew brings 15 years’ experience in the software sector, serving in senior finance roles in public and private equity backed firms both in the UK and USA. Most recently, he was CFO of Kewill, a global leader in multi-modal transportation software solutions, which he helped transition from a public company to private ownership. Prior to that, he worked for a number of Vista portfolio companies including Advanced’s sister company, financial services software provider Misys, and as CFO of Vista’s P2 Energy Solutions.
Follow Andrew Hicks:
About Advanced: Advanced provide software & services for commercial, public and third sector organisations that make the complex simple.
Andrew Hicks
CFO of Advanced
Andrew Hicks is the Chief Financial Officer (CFO) at Advanced, having joined the company in December 2015. He is responsible for leading the Group’s strategic and operational finance, legal and HR departments. He also drives strategic organic and inorganic initiatives across the group. Andrew brings 15 years’ experience in the software sector, serving in senior finance roles in public and private equity backed firms both in the UK and USA. Most recently, he was CFO of Kewill, a global leader in multi-modal transportation software solutions, which he helped transition from a public company to private ownership. Prior to that, he worked for a number of Vista portfolio companies including Advanced’s sister company, financial services software provider Misys, and as CFO of Vista’s P2 Energy Solutions.
Follow Andrew Hicks:
About Advanced: Advanced provide software & services for commercial, public and third sector organisations that make the complex simple.
Graham Baker
Chief Financial Officer of Smith & Nephew
Graham holds an MA degree in Economics from Cambridge University and qualified as a Chartered Accountant and Chartered Tax Adviser with Arthur Andersen. In 1995, he joined AstraZeneca PLC where he worked for 20 years, holding multiple senior roles, including Vice President Finance & Chief Financial Officer, North America (2008-2010), Vice President, Global Financial Services (2010-2013) and Vice President, Finance, International (2013-2015) with responsibility for all emerging markets. Most recently, Graham was Chief Financial Officer of generic pharmaceuticals company Alvogen.
Follow Graham Baker:
About Jardine Strategic Holdings, Smith & Nephew: Smith and Nephew is a manufactures and markets orthopedic devices, sports medicine and ENT technologies.
Gavyn Stear
CFO of YgEia3
Follow Gavyn Stear:
About YgEia3: YgEia3 works with corporations developing comprehensive wellness testing for each company.
Vincent Miceli
Vice President & Chief Financial Officer of NXT-ID
Vincent Miceli, age 56, has extensive hands on experience in financial and operational management and business leadership in both substantial private and public companies. He is also experienced with working with public company Boards of Directors, as well as financial institutions. Vincent Miceli was the Vice-President and Chief Financial Officer/Treasurer of Panolam Industries International, Inc., a company which primarily designs, manufactures and distributes decorative and industrial laminates, from May 2006 to mid-December 2013. Prior to that, Vincent Miceli was the Chief Financial Officer and Corporate Controller of Opticare Health Systems, Inc., a public company which provides integrated eye care services, from 2004 to 2006. Prior to 2004, Vincent Miceli held senior accounting positions at Amphenol Corporation and United Technologies, Inc. Vincent Miceli holds a BS in accounting from Quinnipiac College, an MBA, with a concentration in Finance, from the University of Hartfordand he is an affiliate member of both the AICPA and the CT Society of Certified Public Accountants.
Follow Vincent Miceli:
About NXT-ID: Sensor, Mobile, HealthTech, MedTech
James Rawlingson
Chief Financial Officer of Arix Bioscience
James has substantial experience at board and senior management level gained over 20 years of involvement in financial services and UK public companies. James’ former role was Group CFO of Charles Stanley plc, a leading wealth manager with over £20 billion of funds under management and administration. Previously, James was Group CFO for Coutts Bank, where he was responsible for the global finance function and held a key role in setting strategy. Before this James spent two years at UBS Wealth Management based in Zurich after promotion from his role as CFO of UBS Wealth UK.
Follow James Rawlingson:
About Arix Bioscience: Arix Bioscience is a healthcare and life science company.
Keith Lovell
CFO of Antidote.me
Keith Lovell brings over 15 years’ experience gained from commercial, financial and management positions in a range of blue-chip, entrepreneurial and start-up organisations. Prior to Shazam at Extreme Mobile, Keith played an integral role in formulating commercial and financial plans for an MNVO venture with Vodafone. Previously, he was also responsible for all major network operator and supplier relationships at DX Communications Ltd and played a key role in negotiating the sale of the UK retail business to BT Cellnet, now 02.
Follow Keith Lovell:
About Antidote.me: Antidote is a digital health company that accelerates and improves medical research by combining technologies, data, and business models.
Gerard Smith
CFO of SERMO
Gerard joined SERMO in 2011 as the Chief Financial Officer responsible for the company wide Finance, HR and Legal functions along with Investor Relations. Previously he was EMEA CFO of Acxiom, a global Marketing Services Company with revenues exceeding $1.1 billion, CFO of Easynet, a former BSkyB Company, with revenues of $400 million and has held several international finance leadership roles in Dell Corporation during a period in which the business grew from one billion to $13 billion. Gerard has over 25 years of finance experience and graduated with a Business degree from City University, London and is a Chartered Marketer and Chartered Management Accountant.
Follow Gerard Smith:
About SERMO: SERMO is the social network for doctors.
Wendy Britten
Chief Financial Officer of Congenica
Wendy Britten is a Senior Finance professional with an extensive track record of delivering in leadership positions across a range of industries, including numerous M&A transactions. Most recently Wendy headed up the Group Finance Business Performance team at AstraZeneca, working in close partnership with the CEO, CFO and the Senior Executive Team. Prior to joining AZ Wendy progressed her career in a variety of roles with PricewaterhouseCoopers, starting in Audit and culminating as a Director in M&A in London and New York. Wendy holds a BSc in Mathematics from University of Sheffield and is a qualified Chartered Accountant.
Follow Wendy Britten:
About Congenica: Congenica is a biotechnology company that provides a diagnostic decision support platform.
Duncan Kennedy
Chief Financial Officer of BTG International
Duncan Kennedy joined BTG in December 2005 as Group Financial Controller and in April 2012 he joined the Leadership Team as Group Director of Finance, with management responsibility for the global finance function. Duncan led BTG’s Interventional Oncology business from May 2015 until he began as CFO in January 2018. Prior to joining BTG, Duncan spent six years in the group finance function of Wembley plc, an international leisure group, gaining wide-ranging experience in all aspects of listed company financial reporting and significant involvement in corporate transactions. Duncan qualified as a Chartered Accountant at Arthur Andersen and holds a BSc in Mathematics from Durham University.
Follow Duncan Kennedy:
About BTG International: BTG is a global healthcare company focused on Interventional Medicine.
Guy Mitchell
Chief Financial Officer of Induction Healthcare Group
Follow Guy Mitchell:
About Induction Healthcare Group: Induction Healthcare is a healthcare technology company focused on streamlining the delivery of care by Healthcare Professionals.
John Bradshaw
Chief Financial Officer of Syncona Partners LLP
John Bradshaw is the Chief Financial Officer of Syncona Investment Management Ltd. He has worked extensively with companies in the life science sector as a part-time and interim CFO. He was previously CFO of Gyrus Group PLC and qualified as a chartered accountant with Arthur Andersen. John has a degree in Law from the University of Liverpool.
Follow John Bradshaw:
About Avillion, Syncona Partners LLP: Syncona Partners LLP is a healthcare company focused on investing in and building global leaders in life science.
Fiona Stewart
Chief Financial Officer of Cambridge Epigenetix
Follow Fiona Stewart:
About Cambridge Epigenetix, Fusion Global Capital: Cambridge Epigenetix is using epigenetics to reduce several routine & important diagnostic tests for common cancers to a simple blood draw.
Adeel Ahmad
Chief Financial Officer of Advanz Pharma
Follow Adeel Ahmad:
About Advanz Pharma: ADVANZ PHARMA is a pharmaceutical company focused on serving the needs of patients and healthcare providers.
Gianclaudio Antonelli
Chief Financial Officer of AchilleS Vaccines
Follow Gianclaudio Antonelli:
About AchilleS Vaccines: AchilleS Vaccines is a company that aims to attract some of the industry’s brightest brains.
Barry Knight
CFO of Edinburgh Molecular Imaging
Follow Barry Knight:
About Domainex, Edinburgh Molecular Imaging: Edinburgh Molecular Imaging is a developer of optical molecular imaging technology.
Benjamin Palleiko
Chief Financial Officer of KalVista Pharmaceuticals
Ben joined KalVista as Chief Financial Officer in August 2016. He has over 20 years of industry experience as a life sciences investment banker at firms including Robertson Stephens and SunTrust and a Senior Executive of several public and private biotech companies including SVP & CFO of Ore Pharmaceutical Holdings and Penwest Pharmaceuticals Co. In his roles, Ben has overseen strategic planning, business development, business operations, finance, human resources, legal, and investor relations. He has completed over 50 strategic, licensing and financing transactions and raised more than $2 billion in capital. Ben holds a BA in Quantitative Economics from Tufts University and an MBA in Finance and MA in International Relations from the University of Chicago. He served as a Naval Aviator in the U.S. Navy.
Follow Benjamin Palleiko:
About KalVista Pharmaceuticals: KalVista Pharmaceuticals is an ophthalmology company focused on developing drugs for the treatment of diabetic macular edema (DME).
Theo Harold
CFO of Crescendo Biologics
Theodora Harold is a chartered accountant with significant experience as a Chief Financal Officer and Company Secretary with early stage and growing companies in the biotech sector. She has a background in both industry and corporate finance with 16 years of experience in SMEs in the biotech and hi-tech sectors and has held roles with Cytomyx Holdings plc, RioTech Pharmaceuticals Ltd, OrthoMimetics Ltd, Hybrid Biosystems Ltd, Myotec Therapeutics Ltd and Mission Therapeutics Ltd. Prior to this, Theodora trained with PricewaterhouseCoopers and read Classics at Trinity College, Cambridge.
Follow Theo Harold:
About Crescendo Biologics, Crescendo Biologics, Crescendo Biologics: Crescendo Biologics is engaged in the development of a proprietary drug portfolio based on their VH antibody fragment platform.
Andrew McMeeking
CFO of Prescient Healthcare Group
Andrew joined Prescient’s team in 2012 after holding finance director positions in marketing services companies such as Publicis and Gyro. He is a qualified chartered accountant and holds an honors degree in accountancy from Dundee University. He manages Prescient’s finances and is the company secretary. He was heavily involved in setting up the shared resources service center in the UK and arranging Prescient’s de-merger/MBO in 2014.
Follow Andrew McMeeking:
About Prescient Healthcare Group: Prescient Healthcare Group was founded in London in 1995, originally specializing in competitive insights.
Thad Huston
Chief Financial Officer of LivaNova
Thad Huston is the Chief Financial Officer of LivaNova. Huston joined LivaNova after more than 25 years of healthcare experience at Johnson & Johnson (J&J) where he most recently served as Group Chief Financial Officer, Medical Devices. While at J&J, Huston was pivotal in accelerating the growth for many of its divisions through focused strategies, calculated investments in innovation and streamlined productivity. Huston held various other senior roles while at J&J, including: President of J&J’s Xian-Janssen Pharmaceuticals division in China; Vice President – Finance, Chief Financial Officer and Chief Operations Officer in J&J Pharmaceutical Research and Development; as well as Vice President – Finance and Chief Financial Officer at Ortho-McNeil Pharmaceuticals. Prior to this, he held senior financial roles at various J&J locations in the U.S., China, Belgium, Russia and Hungary. A Certified Management Accountant, Huston holds a Bachelor of Science in finance with an emphasis in accounting from Pennsylvania State University.
Follow Thad Huston:
About LivaNova: LivaNova PLC is a global medical technology company built on nearly five decades of experience and a relentless commitment.
Anjum Ahmad
CFO of Touchlight Genetics
Follow Anjum Ahmad:
About Touchlight Genetics: Touchlight Genetics, a British bio-pharmaceutical company founded in 2007.
Robin Pakenham
Chief Financial Officer of Kind Consumer
Robin Pakenham is the chief financial officer of Kind Consumer.
Follow Robin Pakenham:
About Kind Consumer: Kind Consumer is a healthcare research and development company focused on inhalation technologies.
Richard McCann
Chief Financial Officer and Chief Operating Officer of Kainos
Follow Richard McCann:
About Kainos: Kainos provide digital technology solutions that enable companies to work smarter, faster, better.
Stephen Geater
Chief Financial Officer of Pai Skincare
Stephen Geater is the Chief Financial Officer at Pai Skincare.
Follow Stephen Geater:
About Pai Skincare: Our premium products provide solutions for sensitive skin in all its forms – whether it be dry or oily, youthful or mature.
Bill Fleming
CFO of Ultromics
Bill’s career spans over 25 years in a broad range of finance positions. Holding a law degree from Cambridge University and as a qualified ACMA, Bill has accumulated international FD/CFO experience in small venture-backed companies, large blue chips and the bio-tech arena. Bill served as European Finance Director for Visible Genetics, a pioneering company in the field of nucleic acid diagnostics, subsequently holding senior finance positions for Bayer Healthcare in Europe and the USA. Bill played a leading role in securing investment for Oxford University spinout Oxitec and in its successful acquisition by Intrexon Corporation. Joining Ultromics in February 2018, Bill brings with him extensive experience in life sciences and technology sectors and holds a non-executive directorship at the leading life sciences network, OBN.
Follow Bill Fleming:
About Ultromics: Ultromics clinicians and engineers working together to set new standards for world-class cardiovascular diagnostic tools.
Kim Fieldbinder
Executive Vice President & Chief Financial Officer of SourceMedical-TherapySource
Kim Fieldbinder joined SourceMed as a senior accountant in August of 2001 and is currently the Company’s Executive Vice President and Chief Financial and Administrative Officer. Recently, Kim was named to the Birmingham Business Journal’s prestigious Top 40 Under 40 list for her impressive contributions to the area’s business industry and her work with SourceMed. During her time with the company, Kim has not only paved the way for female leaders as the first woman to be made a SourceMed executive, but has also helped create a leadership training and mentoring program to provide guidance and advisement to up-and-coming employees and the company’s first corporate giving program, Source Cares, which focuses on bringing hope to pediatric cancer patients. Prior to joining SourceMed, Kim was a senior accountant at Ernst & Young, LLP where she assisted in the financial audits of public companies. Kim is a certified public accountant and holds a Bachelor’s degree in accounting from the University of Alabama at Birmingham as well as a Master’s degree in accounting from the University of Alabama. Kim has been in the Birmingham market for over 18 years. She engages projects with intensity and a commitment to excellence. Kim is a team builder, facilitator, and problem- solver who propels companies forward. She resides in Birmingham with her husband and their son and spends her free time serving on the boards of many local charities.
Follow Kim Fieldbinder:
About Randall-Reilly, SourceMedical-TherapySource: SourceMedical-TherapySource provider of outpatient information solutions.
Robin Sibson
CFO of Clinigen Group
Follow Robin Sibson:
About Clinigen Group: Clinigen is a rapidly-growing specialty pharmaceutical and services company,
Tom Hadfield
Chief Financial Officer of Oxehealth
Tom Hadfield is the Chief Financial Officer at Oxehealth.
Follow Tom Hadfield:
About Oxehealth: SaaS workflow solution gives carers and custodians more time for hands on care where and when it’s needed most.
Peter Worrall
CFO of Rex Bionics
Follow Peter Worrall:
About Rex Bionics: REX is a hands-free, self supporting, independently controlled, robotic mobility device.
Robbie Bell
Chief Financial Officer of Holland & Barrett
Follow Robbie Bell:
About Holland & Barrett, McColl’s Retail Group, Ultimate Products: Holland & Barrett is a chain of health food shops with over 1,300 stores in 16 countries.
Julien Cotta
CFO of Inion
Follow Julien Cotta:
About Inion: Inion is a medical devices company focused on the development and commercialization of innovative biodegradable applications.
Jean-Luc Janet
Chief Financial Officer of Outcomes First Group Ltd.
Follow Jean-Luc Janet:
About Outcomes First Group Ltd.: Outcomes First Group Ltd provides social care and/or education services.
Steve Whant
Chief Financial Officer and Director of NiQ Health
Founding Director of PMSI, London based strategy consulting entity est. 1989. Support for new market development opportunities and particular focus on BI development. Multiple Healthcare transactions & ongoing client base in Healthcare sector.
Follow Steve Whant:
About AlignAlytics, NiQ Health, PMSI Strategy LLP: One of the leading care management systems for hospitals and aged care applications in January 2010.
Bob Finnigan
Chief Financial Officer of Monica Healthcare
Bob qualified as a chartered accountant with KPMG (Thomson McLintock) and worked for over 20 years’ in various senior financial roles for a large international market research company, including 6 years as Regional CFO. Following that, for the last 8 years he has operated as an independent specialist providing CFO services to early-stage businesses and undertaking financial due diligence work on VCT investments. Bob has put in place and manages a robust financial control and reporting system and brings a high level of financial experience to the management team.
Follow Bob Finnigan:
About Monica Healthcare: Monica Healthcare is developing a series of wearable devices.
Nic Hellyer
Chief Financial Officer of Byotrol
Follow Nic Hellyer:
About Byotrol, Pelatro: Byotrol operates as a developer of consumer and professional antimicrobial technologies and products.
Martin Cartwright
Chief Financial Officer of Owlstone Medical
Martin is an energetic and commercially oriented Chartered Accountant. He has nearly 30 years’ experience of working in the technology and services sectors. He has worked in a number of SMEs as CFO from start up through to publicly quoted companies. Previous companies include Cadence Design Systems (Electronic Design Automation), GE Smallworld (Geographic Information Systems), Ubisense (Real Time Location Systems). He always strives to be a value added business partner to the management team and has a broad range of management experience encompassing legal and customer contracts, human resources, investor relations, procurement, as well as financial accounting, planning, forecasting, tax and treasury. Martin qualified as a chartered accountant with Coopers & Lybrand (now PwC).
Follow Martin Cartwright:
About Owlstone Medical: Owlstone Medical is a diagnostics company that developed a non-invasive breathalyzer for infectious disease detection.
John Bugos
Chief Financial Officer of North American Partners in Anesthesia
Follow John Bugos:
About North American Partners in Anesthesia: North American Partners in Anesthesia (NAPA) is the leading single specialty anesthesia and perioperative management company.
John A. Tattory
Chief Financial Officer of Windtree Therapeutics
Joined Discovery Labs in January 2008 and serves as Discovery Labs’ Senior Vice President and Chief Financial Officer, after several years as Vice President, Finance and Chief Accounting Officer. Mr. Tattory brings to Discovery Labs more than 20 years of finance and accounting experience, including eight years as a CPA and auditor at Ernst & Young LLP and eight years at Bristol-Myers Squibb (BMS) managing financial matters for various BMS pharmaceutical businesses including international operations. Mr. Tattory is currently responsible for managing the Company’s financial and accounting operations, including financial planning and forecasting, financial analysis, accounting systems and policies, internal controls, commercial accounting matters including sales forecasting and product pricing, cost accounting, and financial reporting.
Follow John A. Tattory:
About Windtree Therapeutics: Windtree is a clinical-stage focused on developing novel surfactant therapies for respiratory diseases and other potential applications.
Darren Millington
Chief Financial Officer of Rayner Surgical Group
Darren joined the Rayner Group Board in August 2014 with 8 years’ experience as a CFO in public and private companies. Following an MSc in Theoretical Physics, Darren worked in new product development for AEA Technology before joining Arthur Andersen (later Deloitte) to become a chartered accountant. Once qualified he worked for IP Group plc as part of a small team helping commercialise innovative university technologies. He then joined one of these spin-out companies, Summit Corporation, which specialises in developing drugs for muscular dystrophy and TB. The company was successfully floated in 2004 on the AIM market. Darren’s most recent position was as CFO at Gama Aviation, an aviation and engineering company with operations around the world and revenues over $200m. In each of his recent roles Darren has helped the companies grow through investment and acquisition. Darren is a keen cyclist who can be found climbing the Sussex hills most weekends.
Follow Darren Millington:
About Rayner Surgical Group: Rayner Surgical Group is manufactures Intraocular lenses and associated instruments used in cataract surgery.
James Bailey
CFO of emoquo
Follow James Bailey:
About emoquo: Emoquo is an award winning digital coaching app and real-time people analytics platform for everyone at work.
Kristoffer Laurson
CFO of Beat2Phone
Follow Kristoffer Laurson:
About Beat2Phone, Camco Clean Energy: Beat2Phone is a simple, reliable and easy-to-use ECG device and application for people with heart problems.
Raymond Spencer
CFO of OxStem
Raymond Spencer, CFO has over 30 years’ experience as a senior financial officer in biotech. For 12 years he was the CFO of LSE listed Antisoma plc. Whilst at Antisoma he was instrumental in completing the IPO in 1998, several fund-raising rounds that totalled over £100 million, the acquisition of two private US biotech companies and the closing of three licensing deals with big pharma with total upfront licence fees exceeding £100m. Raymond was CFO for AIM listed Summit plc for 5 years to July 2014 having completed a restructuring of the company, raised over £20m in equity financing and the acquisition of the Oxford University spin-out MuOx Ltd. Raymond is currently part-time founder, Director and CFO of MGB-Biopharma Ltd, which has raised over £6m from angel investors, Scottish Enterprise and won a Biomedical Catalyst award from Innovate UK to progress drugs for treatment of anti-microbial resistance. He has also established his own consultancy company, Bio-CFO Ltd providing services to biotech and cleantech companies. Raymond qualified as a chartered accountant with KPMG in 1979.
Follow Raymond Spencer:
About MGB Biopharma, OxStem: OxStem is a drug discovery company.
Mark Ground
CFO of Cygnet Health Care
CFO at Cygnet Health Care
Follow Mark Ground:
About Cygnet Health Care: Cygnet Health Care Limited provides mental health services.
